US Patent Issued to Think Therapeutics on May 6 for "Compositions for optimized BCR-ABL peptide vaccines" (Massachusetts Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,554, issued on May 6, was assigned to Think Therapeutics Inc. (Newton, Mass.).

"Compositions for optimized BCR-ABL peptide vaccines" was invented by David Kenneth Gifford (Newton, Mass.) and Brandon Carter (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides for methods, systems, and compositions of nucleic acid and peptide sequences. The present disclosure provides for a nucleic acid sequence encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 1 to 44. The present disclosure also provides for an immunogenic peptide composition comprising two or more peptides selecte...